البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
CEFOVICIN AS SODIUM SALT
ZOETIS ISRAEL HOLDING B.V., ISRAEL
POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
CEFOVICIN AS SODIUM SALT 80 MG/DOSE
S.C
Required
HAUPT PHARMA LATINA S.R.L, ITALY
Dogs : For the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with Staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. For the treatment of urinary tract infections associated with Escherichia coli and/or Proteus spp.As adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with Porphyromonas spp. and Prevotella spp. Cats : For the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. For the treatment of urinary tract infections associated with escherichia coli.
2020-11-30
Component Pharma Code GTIN CR Number Description Artwork Code Supplier Market Perigord Nº Colours TEXT SIZE The BODY text on this A/W is at: Dimensions SKU N o Drawing Number Date: Time: Proof Nº Tel: +353 (0)1 440 3222 Web: www.perigord-as.com E-mail: PerigordZoetis@perigord-as.com GLOBAL EXTERNAL SUPPLY 51752269 HAUPT PHARMA LATINA SRL Israel 721005 Leaflet XXXIXX N/A 200013610 N/A 7.0 pt 03 13 : 08 Black Profile INS CONVENIA SPO 10ML ISR 30 MAR 2023 PAGE 1 OF 6 Dimensions 140 x 229 mm Folded Dimensions 120 x 209 mm Drawing Number FIBIN_140X229X3 32GR VETERINARY MEDICINE PACKAGE LEAFLET This medicine is dispensed with a veterinarian’s prescription only For use in animals only 1. NAME, FORM AND STRENGTH OF THE VETERINARY MEDICINE Convenia Veterinary 2. ACTIVE INGREDIENTS Each vial of lyophilised powder contains: cefovecin (as sodium salt) 852 mg. After reconstitution according to the instructions, the solution for injection contains: cefovecin as sodium salt 80 mg/ml. The list of inactive ingredients is provided in section 13. 3. WHAT IS THIS MEDICINE INTENDED FOR For use only for the following infections requiring prolonged treatment. The antimicrobial activity of Convenia following a single administration lasts for up to 14 days. Dogs: For the treatment of skin and soft tissue infections including pyoderma, wounds and abscesses associated with _Staphylococcus _ _intermedius_, β -haemolytic _streptococci, _ _Escherichia _ _coli_ and/or _Pasteurella multocida_. For the treatment of urinary tract infections associated with _Escherichia coli_ and/or _Proteus_ spp. As adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with _Porphyromonas_ spp. and _Prevotella_ spp. Cats: For the treatment of skin and soft tissue abscesses and wounds associated with _Pasteurella _ _multocida_, _Fusobacterium_ spp., _Bacteroides_ spp., _Prevotella oralis_, β-haemolytic _ streptococci_ and/or _Staphylococcus intermedius_. For the treatment of اقرأ الوثيقة كاملة
Convenia Veterinary LPD CC 12.04.2022 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Convenia Veterinary 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Each vial of lyophilised powder contains 852 mg cefovecin (as sodium salt) When reconstituted according to label instruction, the solution for injection contains 80.0 mg/ml cefovecin (as sodium salt) For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Powder and solvent for solution for injection. The powder is off-white to yellow and the diluent (solvent) is a clear, colourless liquid. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and Cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For use only for the following infections which require prolonged treatment. The antimicrobial activity of Convenia following a single injection lasts for up to 14 days. Dogs: For the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with Staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. For the treatment of urinary tract infections associated with Escherichia coli and/or Proteus spp. As adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with Porphyromonas spp. and Prevotella spp. Cats: For the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. For the treatment of urinary tract infections associated with escherichia coli. 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to cephalosporin or penicillin antibiotics. Do not use in small herbivores (including guinea pigs and rabbits). Do not use in dogs and cats less than 8 weeks old. Convenia Veterinary LPD CC 12.04.2022 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in anima اقرأ الوثيقة كاملة